ライフサイエンスコーパス: receptor activity-modifying protein

1 niche(3,4,6), CGRP acts directly on HSCs via receptor activity modifying protein 1 (RAMP1) and the ca

2 niche(3,4,6), CGRP acts directly on HSCs via receptor activity modifying protein 1 (RAMP1) and the ca

3 Calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) comprise a

4 Receptor activity modifying protein 1 (RAMP1) is an inte

5 CGRP acted through receptor activity modifying protein 1 (RAMP1) on meninge

6 that 5-HTR1E can regulate the expression of Receptor activity modifying protein 1 (RAMP1), Nuclear r

7 esions contain both CGRP and its coreceptor, receptor activity modifying protein 1 (RAMP1).

8 lacking functional CGRP receptors on ECs (EC receptor activity modifying protein 1 [RAMP1] knockout m

9 on together with its two accessory proteins, receptor activity modifying protein 1 and CGRP-receptor

10 he calcitonin receptor-like receptor and the receptor activity modifying protein 1, within the area o

11 bunits calcitonin receptor-like receptor and receptor activity modifying protein 1.

12 alcitonin receptor-like receptor (CRLR) with receptor activity-modifying protein 1 (RAMP 1).

13 Herein, we identify the receptor activity-modifying protein 1 (RAMP1) as a direc

14 the calcitonin receptor (CTR) interact with receptor activity-modifying protein 1 (RAMP1) at the cel

15 citonin receptor-like receptor (CLR) and the receptor activity-modifying protein 1 (RAMP1) comprise a

16 calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1), and the d

17 ith calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), beta-arre

18 Our findings demonstrate that a single gene, receptor activity-modifying protein 1 (RAMP1), can be a

19 calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1), respectiv

20 calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1).

21 receptor (calcitonin receptor-like receptor/receptor activity modifying protein-1, CLR/RAMP1) implic

22 in vitro and in vivo by expression of human receptor activity-modifying protein-1 (hRAMP1), an oblig

23 evealed marked anatomical gradients for both receptor activity-modifying protein-1 (RAMP-1) and calci

24 lcitonin receptor-like receptor (Calcrl) and receptor activity modifying protein 2/3, are highly expr

25 citonin receptor-like receptor (CLR) and the receptor activity-modifying protein 2 (RAMP2) comprise a

26 hrough calcitonin receptor-like receptor and receptor activity-modifying protein 2 and modulates lung

27 ADM, calcitonin receptor-like receptor, and receptor activity-modifying protein 2 in vitro decreased

28 calcitonin receptor-like receptor (CLR), and receptor activity-modifying proteins 2 and 3 (RAMP2 and

29 iation with the receptor-interacting protein receptor activity-modifying protein-2 (RAMP2), and the r

30 through the calcitonin receptor (CalcR) and receptor activity modifying protein 3 (RAMP3) to inhibit

31 e calcitonin receptor (CTR) and one of three receptor activity-modifying proteins, are promising obes

32 RAMPs (receptor activity modifying proteins) impart remarkable

33 ptor, calcitonin receptor-like receptor, and receptor activity-modifying proteins in human microvesse

34 mbrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expre

35 It requires receptor activity modifying protein (RAMP) 1 to give a c

36 eceptor (CRLR) with different members of the receptor activity modifying protein (RAMP) family, which

37 A small co-receptor from zebrafish, receptor activity modifying protein (RAMP)-like triterpe

38 CR) which requires coexpression of different receptor activity modifying proteins (RAMP) to become a

39 eptor (CRLR) and an accessory protein called receptor activity-modifying protein (RAMP) 1.

40 r the human calcitonin receptor (CTR), human receptor activity-modifying protein (RAMP)-1, RAMP1 (AMY

41 A library, we isolated a cDNA clone encoding receptor activity-modifying protein (RAMP)-like triterpe

42 Receptor activity-modifying proteins (RAMP1-3) determine

43 ptor (CLR), which heterodimerizes with three receptor activity-modifying proteins (RAMP1-3) that dete

44 Association of receptor activity-modifying proteins (RAMP1-3) with the

45 lcrl) when the receptor is associated with a receptor activity-modifying protein (RAMP2).

46 alcitonin receptor-like receptor (CRLR), and receptor activity modifying proteins (RAMPs) have become

47 Receptor activity-modifying proteins (RAMPs 1-3) are sin

48 Receptor activity-modifying proteins (RAMPs) 1, 2, and 3

49 Receptor activity-modifying proteins (RAMPs) are widely

50 Receptor activity-modifying proteins (RAMPs) form comple

51 The three receptor activity-modifying proteins (RAMPs) have been r

52 Receptor activity-modifying proteins (RAMPs) interact wi

53 Receptor activity-modifying proteins (RAMPs) modulate th

54 Receptor activity-modifying proteins (RAMPs) offer the p

55 or-like receptor (CRLR) and one of the three receptor activity-modifying proteins (RAMPs) showed that

56 ified an interaction of CXCR4 and ACKR3 with receptor activity-modifying proteins (RAMPs), and RAMP3

57 er of GPCRs have been shown to interact with receptor activity-modifying proteins (RAMPs), which can

58 ith one of three accessory proteins known as receptor activity-modifying proteins (RAMPs).

59 eceptor-like receptor (CLR) and one of three receptor activity-modifying proteins (RAMPs).

60 Receptor-activity-modifying proteins (RAMPs) are single

61 Receptor-activity-modifying proteins (RAMPs) are ubiquit